220 related articles for article (PubMed ID: 11315099)
1. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.
Ibrahim T; Leong I; Sanchez-Sweatman O; Khokha R; Sodek J; Tenenbaum HC; Ganss B; Cheifetz S
Clin Exp Metastasis; 2000; 18(3):253-60. PubMed ID: 11315099
[TBL] [Abstract][Full Text] [Related]
2. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
[TBL] [Abstract][Full Text] [Related]
4. Bone sialoprotein mRNA expression and ultrastructural localization in fetal porcine calvarial bone: comparisons with osteopontin.
Chen J; McKee MD; Nanci A; Sodek J
Histochem J; 1994 Jan; 26(1):67-78. PubMed ID: 8169152
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.
Bellahcène A; Castronovo V
Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854
[TBL] [Abstract][Full Text] [Related]
6. Bone sialoprotein in developing porcine dental tissues: cellular expression and comparison of tissue localization with osteopontin and osteonectin.
Chen J; McCulloch CA; Sodek J
Arch Oral Biol; 1993 Mar; 38(3):241-9. PubMed ID: 8489418
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption.
Chen J; Singh K; Mukherjee BB; Sodek J
Matrix; 1993 Mar; 13(2):113-23. PubMed ID: 8492741
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of bone sialoproteins in vitamin D-deficient rBSP2.7Luc transgenic mice.
Chen JJ; Jin H; Ranly DM; Sodek J; Boyan BD
J Bone Miner Res; 1999 Feb; 14(2):221-9. PubMed ID: 9933476
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers.
Gillespie MT; Thomas RJ; Pu ZY; Zhou H; Martin TJ; Findlay DM
Int J Cancer; 1997 Dec; 73(6):812-5. PubMed ID: 9399657
[TBL] [Abstract][Full Text] [Related]
11. Regulation of bone sialoprotein and osteopontin mRNA expression by dexamethasone and 1,25-dihydroxyvitamin D3 in rat bone organ cultures.
Chen J; Thomas HF; Sodek J
Connect Tissue Res; 1996; 34(1):41-51. PubMed ID: 8835847
[TBL] [Abstract][Full Text] [Related]
12. Developmental appearance and distribution of bone sialoprotein and osteopontin in human and rat cementum.
Bosshardt DD; Zalzal S; McKee MD; Nanci A
Anat Rec; 1998 Jan; 250(1):13-33. PubMed ID: 9458064
[TBL] [Abstract][Full Text] [Related]
13. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack.
Fedarko NS; Fohr B; Robey PG; Young MF; Fisher LW
J Biol Chem; 2000 Jun; 275(22):16666-72. PubMed ID: 10747989
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone sialoprotein mRNA during bone formation and resorption induced by colchicine in rat tibial bone marrow cavity.
Arai N; Ohya K; Kasugai S; Shimokawa H; Ohida S; Ogura H; Amagasa T
J Bone Miner Res; 1995 Aug; 10(8):1209-17. PubMed ID: 8585425
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
[TBL] [Abstract][Full Text] [Related]
18. Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.
Adwan H; Bäuerle T; Najajreh Y; Elazer V; Golomb G; Berger MR
Int J Oncol; 2004 May; 24(5):1235-44. PubMed ID: 15067347
[TBL] [Abstract][Full Text] [Related]
19. Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro.
Zhu X; Luo C; Ferrier JM; Sodek J
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):637-43. PubMed ID: 9169595
[TBL] [Abstract][Full Text] [Related]
20. Distribution and synthesis of bone sialoprotein in metaphyseal bone of young rats show a distinctly different pattern from that of osteopontin.
Hultenby K; Reinholt FP; Norgård M; Oldberg A; Wendel M; Heinegård D
Eur J Cell Biol; 1994 Apr; 63(2):230-9. PubMed ID: 8082647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
